181 related articles for article (PubMed ID: 31642863)
1. Management of attention deficit/hyperactivity disorder and the use of stimulants in prison. Evaluation of the risks and benefits.
Fructuoso A
Rev Esp Sanid Penit; 2019; 21(2):113-114. PubMed ID: 31642863
[No Abstract] [Full Text] [Related]
2. Attention deficit hyperactivity disorder in prison.
Ghanizadeh A; Akhondzadeh S
J Am Acad Psychiatry Law; 2009; 37(2):278. PubMed ID: 19535565
[No Abstract] [Full Text] [Related]
3. What exactly are the benefits of stimulants for ADHD?
Advokat C
J Atten Disord; 2009 May; 12(6):495-8. PubMed ID: 19380518
[No Abstract] [Full Text] [Related]
4. An update on attention deficit disorder.
Harv Ment Health Lett; 2004 May; 20(11):4-7. PubMed ID: 15153391
[No Abstract] [Full Text] [Related]
5. ADHD: disorder or discipline problem?
Faraone SV; Biederman J
Science; 2001 Feb; 291(5508):1488-9. PubMed ID: 11234074
[No Abstract] [Full Text] [Related]
6. Attention-deficit/hyperactivity disorder treatment and later drug use.
Furman L
Pediatrics; 2003 Dec; 112(6 Pt 1):1459-60; author reply 1459-60. PubMed ID: 14654634
[No Abstract] [Full Text] [Related]
7. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
Faraone SV; Wilens TE
J Clin Psychiatry; 2007; 68 Suppl 11():15-22. PubMed ID: 18307377
[TBL] [Abstract][Full Text] [Related]
8. Comment on Lambert and Hartsough (1998).
Mick E; Biederman J; Faraone SV
J Learn Disabil; 2000; 33(4):314; author reply 314-6. PubMed ID: 15493092
[No Abstract] [Full Text] [Related]
9. Attention deficit hyperactivity disorder and substance use disorders.
Bukstein OG
Curr Top Behav Neurosci; 2012; 9():145-72. PubMed ID: 21789746
[TBL] [Abstract][Full Text] [Related]
10. The top ten reasons to limit prescription of controlled substances in prisons.
Burns KA
J Am Acad Psychiatry Law; 2009; 37(1):50-2. PubMed ID: 19297633
[TBL] [Abstract][Full Text] [Related]
11. Physician handling of prescription stimulants.
Croft HA
Pediatr Ann; 2006 Aug; 35(8):557-62. PubMed ID: 16986450
[TBL] [Abstract][Full Text] [Related]
12. ADHD: monitoring for and managing stimulant adverse effects.
Mercer M; Farver D
S D Med; 2013 Dec; 66(12):511, 513. PubMed ID: 24527549
[No Abstract] [Full Text] [Related]
13. Methylphenidate: abuse and addiction.
Prescrire Int; 2012 Oct; 21(131):241. PubMed ID: 23189380
[No Abstract] [Full Text] [Related]
14. Attention deficit hyperactivity disorder in prison: a treatment protocol.
Appelbaum KL
J Am Acad Psychiatry Law; 2009; 37(1):45-9. PubMed ID: 19297632
[TBL] [Abstract][Full Text] [Related]
15. Update on Attention-Deficit/Hyperactivity Disorder.
Soileau EJ
Adolesc Med State Art Rev; 2014 Aug; 25(2):502-19. PubMed ID: 27132328
[No Abstract] [Full Text] [Related]
16. Stimulant treatment of ADHD and risk of sudden death in children.
Vitiello B; Towbin K
Am J Psychiatry; 2009 Sep; 166(9):955-7. PubMed ID: 19528196
[No Abstract] [Full Text] [Related]
17. Stimulant treatment for ADHD may not increase risk of substance abuse.
Harv Ment Health Lett; 2008 Jun; 24(12):7. PubMed ID: 18946888
[No Abstract] [Full Text] [Related]
18. Does stimulant treatment lead to substance use disorders?
Faraone SV; Wilens T
J Clin Psychiatry; 2003; 64 Suppl 11():9-13. PubMed ID: 14529324
[TBL] [Abstract][Full Text] [Related]
19. Authors' reply.
Groenman AP; Oosterlaan J; Rommelse NN; Franke B; Greven CU; Hoekstra PJ; Hartman CA; Luman M; Roeyers H; Oades RD; Sergeant JA; Buitelaar JK; Faraone SV
Br J Psychiatry; 2014 Jun; 204(6):490-1. PubMed ID: 25029693
[No Abstract] [Full Text] [Related]
20. Stimulant treatment for ADHD.
Verma R; Apala ; Kumari S; Dhiman V
Br J Psychiatry; 2014 Jun; 204(6):490. PubMed ID: 25029692
[No Abstract] [Full Text] [Related]
[Next] [New Search]
